BR112013009579A2 - método e comprimido - Google Patents

método e comprimido

Info

Publication number
BR112013009579A2
BR112013009579A2 BR112013009579A BR112013009579A BR112013009579A2 BR 112013009579 A2 BR112013009579 A2 BR 112013009579A2 BR 112013009579 A BR112013009579 A BR 112013009579A BR 112013009579 A BR112013009579 A BR 112013009579A BR 112013009579 A2 BR112013009579 A2 BR 112013009579A2
Authority
BR
Brazil
Prior art keywords
tablet
Prior art date
Application number
BR112013009579A
Other languages
English (en)
Inventor
Jean-Pierre Etchegaray
Ludovic Bussard
Sandrine Segura
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of BR112013009579A2 publication Critical patent/BR112013009579A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BR112013009579A 2010-10-21 2011-10-21 método e comprimido BR112013009579A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34484210P 2010-10-21 2010-10-21
FR1058610 2010-10-21
PCT/EP2011/068443 WO2012059338A1 (en) 2010-10-21 2011-10-21 Sustained-release tablet and process for preparing the same

Publications (1)

Publication Number Publication Date
BR112013009579A2 true BR112013009579A2 (pt) 2016-07-12

Family

ID=44065500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009579A BR112013009579A2 (pt) 2010-10-21 2011-10-21 método e comprimido

Country Status (11)

Country Link
US (2) US20120100214A1 (pt)
EP (1) EP2629761B1 (pt)
JP (1) JP2013540146A (pt)
KR (1) KR20140011302A (pt)
CN (1) CN103228268A (pt)
AU (1) AU2011325371A1 (pt)
BR (1) BR112013009579A2 (pt)
CA (1) CA2814896A1 (pt)
MX (1) MX2013004227A (pt)
RU (1) RU2013123055A (pt)
WO (1) WO2012059338A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842802B2 (en) * 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
US9511031B2 (en) 2014-10-08 2016-12-06 Mayne Pharma International Pty. Ltd. Controlled release doxycycline
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
US9295652B1 (en) 2014-10-08 2016-03-29 Mayne Pharma International Pty. Ltd. Controlled release doxycycline
US9569638B2 (en) 2014-12-31 2017-02-14 Google Inc. Trusted computing
CN108653229A (zh) * 2018-06-08 2018-10-16 华益药业科技(安徽)有限公司 一种四环素薄膜包衣片及其制备方法
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
UY39094A (es) * 2020-02-27 2021-07-30 Hk Inno N Corp Composición farmacéutica que comprende compuesto derivado de bencimidazol
FR3109089B1 (fr) 2020-04-08 2023-04-14 Cvasthera Composition pharmaceutique pour le traitement des maladies inflammatoires intestinales
KR102340454B1 (ko) 2020-05-20 2021-12-20 주식회사 티케이씨 기판 처리장치
FR3134314A1 (fr) 2022-04-08 2023-10-13 Cvasthera Composition pharmaceutique à base de vorapaxar et son utilisation pour le traitement des maladies inflammatoires intestinales

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003176223A (ja) * 2001-12-13 2003-06-24 Nissan Chem Ind Ltd コーチング方法
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP2204168B1 (en) * 2003-04-07 2015-01-14 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
JP2007507491A (ja) * 2003-09-29 2007-03-29 シージェー コーポレーション 徐放性製剤
CN1613447A (zh) * 2003-11-05 2005-05-11 北京双鹤药业股份有限公司 盐酸多乐西汀肠溶缓释片制剂
CN101437494A (zh) * 2006-05-09 2009-05-20 马林克罗特公司 0级的修饰释放固体剂型
AU2007249947B2 (en) * 2006-05-09 2013-03-21 SpecGx LLC Zero-order modified release solid dosage forms
US20070286902A1 (en) * 2006-06-07 2007-12-13 Abrika Pharmaceuticals Dosage forms comprising a short acting sedative-hypnotic or salt thereof
CN101822650B (zh) * 2010-04-28 2012-06-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 一种盐酸米诺环素缓释片及其制备方法

Also Published As

Publication number Publication date
CN103228268A (zh) 2013-07-31
CA2814896A1 (en) 2012-05-10
EP2629761B1 (en) 2018-05-30
KR20140011302A (ko) 2014-01-28
JP2013540146A (ja) 2013-10-31
RU2013123055A (ru) 2014-11-27
AU2011325371A1 (en) 2013-05-02
EP2629761A1 (en) 2013-08-28
US20140199469A1 (en) 2014-07-17
WO2012059338A1 (en) 2012-05-10
US20120100214A1 (en) 2012-04-26
MX2013004227A (es) 2013-05-30

Similar Documents

Publication Publication Date Title
BR112013001592A2 (pt) artigo e método
BR112013016969A2 (pt) aparelho e método
BR112012017441A2 (pt) compostos e métodos
BR112012015988A2 (pt) método
DK2428450T3 (da) Doseringsmetode og doseringsindretning
BR112012027159A2 (pt) estrutura e método
BR112013009489A2 (pt) aparelho e método de conexão
BR112012028015A2 (pt) aparelho e método
BR112013007499A2 (pt) piridazinonas - métodos de criação e usos
IT1403628B1 (it) Dispositivo assicuratore e discensore
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
BR112013010847A2 (pt) artigo e método
BR112013013584A2 (pt) endoscópio, e, método
BR112013009579A2 (pt) método e comprimido
DK2613884T3 (da) Findelingsindretning
BR112014010450A2 (pt) composição e método
BR112013016641A2 (pt) artigo e método
BR112013009024A2 (pt) método
BR112012023891A2 (pt) método
DK2704744T3 (da) Komplementfaktor-b-analoger og anvendelser deraf
DOP2012000278A (es) Tableta enterica
DK2488043T3 (da) Forbedret ernæringstablet
FR2964937B1 (fr) Triporteur et direction de triporteur
BR112014010860A2 (pt) composição e método
BR112012021749A2 (pt) processos e compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.